文献速递心力衰竭与心肌病

Asb2-KIF11 轴通过恢复溶酶体分布与线粒体稳态保护心脏免于心力衰竭

Asb2-KIF11 Axis Protects Against Heart Failure by Restoring Lysosomal Distribution and Mitochondrial Homeostasis.
PubMed 文献 · Circulation · 2026-09-22

该研究利用雄性可诱导心肌细胞特异性 Asb2 敲除小鼠及主动脉缩窄诱导的心肌肥厚和衰老模型,探讨 Asb2 在心脏重构中的作用。结果显示 Asb2 缺失通过损害 KIF11 泛素化降解导致溶酶体外周分布异常,破坏自噬体-溶酶体融合,引起线粒体功能障碍并自发进展为心力衰竭。恢复 Asb2 表达或抑制 KIF11 可改善自噬流与线粒体稳态,逆转病理性心脏重构。

要点

  • Asb2β 在多种人类心肌病及肥厚小鼠心脏中表达显著降低。
  • 心肌细胞 Asb2 缺失可自发导致心脏肥厚和心力衰竭。
  • 抑制 KIF11 可恢复自噬流与线粒体稳态,逆转病理性心脏重构。

核心结论

  • Asb2 是心肌细胞线粒体质量控制的新型调控因子,通过 KIF11 介导的溶酶体分布发挥作用。
  • 靶向 Asb2-KIF11 轴可能是改善慢性心力衰竭中线粒体稳态和心肌细胞功能的有前景策略。

研究设计与样本

  • 研究采用雄性可诱导心肌细胞特异性 Asb2 敲除小鼠,探究 Asb2 在心脏重构中的作用。
  • 在主动脉缩窄诱导的心肌肥厚及衰老模型中,使用腺相关病毒 9 介导的心肌细胞特异性 Asb2 过表达和 KIF11 下调进行干预。
  • 采用 RNA 测序、代谢物谱分析和质谱技术评估 Asb2 调控心脏代谢与肥厚的分子机制。

主要发现

  • Asb2β 表达在多种人类心肌病及肥厚小鼠心脏中显著降低。
  • 成年雄性小鼠中诱导性 Asb2 缺失可自发导致心脏肥厚和心力衰竭,并伴功能障碍线粒体的进行性蓄积及代谢失调。
  • Asb2 缺乏损害 KIF11 的泛素化降解,引起溶酶体外周分布异常,破坏自噬体-溶酶体融合,导致晚期自噬流受损和代谢紊乱。
  • 腺相关病毒 9 介导恢复 Asb2 表达可减轻压力超负荷诱导及年龄相关的心脏肥厚和心力衰竭。
  • KIF11 的遗传学和药理学抑制均可恢复自噬流和线粒体稳态,逆转 Asb2 缺陷心脏及主动脉缩窄诱导心脏功能障碍中的病理性重构。

临床怎么用

  • Asb2-KIF11 轴可作为慢性心力衰竭中线粒体质量控制紊乱的潜在干预靶点。
  • KIF11 的药理学抑制可能为恢复自噬流和线粒体稳态提供可行的治疗途径。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Heart failure remains a leading cause of mortality globally, driven by persistent mitochondrial dysfunction and maladaptive cardiac hypertrophy. Although impaired autophagic flux contributes to cardiac deterioration, the precise molecular mechanisms are still unclear. The ubiquitin-proteasome system serves as a critical regulator linking protein ubiquitination to autophagic flux and mitochondrial homeostasis. Asb2 (ankyrin repeat-containing protein with suppressor of cytokine signaling box 2), a muscle-specific E3 ubiquitin ligase essential for embryonic cardiogenesis, is uncharacterized in adult cardiac homeostasis and disease pathogenesis. METHODS: Male mice with inducible cardiomyocyte-specific Asb2 knockout were generated to investigate Asb2's role in cardiac remodeling. Adeno-associated virus 9-mediated cardiomyocyte-specific Asb2 overexpression and KIF11 (kinesin family member 11) downregulation were used in transverse aortic constriction-induced hypertrophy and aging models. RNA sequencing, metabolite profiling, and mass spectrometry were used to assess the molecular mechanism by which Asb2 regulates cardiac metabolism and hypertrophy. RESULTS: Asb2β expression was significantly reduced in multiple forms of human cardiomyopathy and in hypertrophic murine hearts. Inducible Asb2 deletion in adult male mice led to the spontaneous development of cardiac hypertrophy and heart failure, accompanied by progressive accumulation of dysfunctional mitochondria and metabolic dysregulation. Mechanistically, Asb2 deficiency impaired ubiquitin-mediated degradation of KIF11, causing aberrant peripheral lysosomal redistribution and disrupting autophagosome-lysosome fusion, which resulted in impaired late-stage autophagic flux and metabolic disturbances. Notably, therapeutic restoration of Asb2 expression via adeno-associated virus 9-mediated delivery attenuated pressure overload-induced and age-related cardiac hypertrophy and heart failure. Moreover, both genetic and pharmacological inhibition of KIF11 effectively restored autophagic flux and mitochondrial homeostasis, thereby reversing pathological cardiac remodeling in Asb2-deficient hearts and transverse aortic constriction-induced cardiac dysfunction. CONCLUSIONS: Asb2 is a novel regulator of mitochondrial quality control in cardiomyocytes via KIF11-mediated lysosomal redistribution. Targeting the Asb2-KIF11 axis may be a promising strategy for improving mitochondrial homeostasis and cardiomyocyte function in chronic heart failure.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Lv, Sha, Peng, et al. Asb2-KIF11 Axis Protects Against Heart Failure by Restoring Lysosomal Distribution and Mitochondrial Homeostasis. Circulation. 2026. PMID: 42770210. doi:10.1161/CIRCULATIONAHA.126.080625

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。